152 related articles for article (PubMed ID: 7745829)
21. Correlation between histological effects on the main tumors and nodal status after chemoradiotherapy for squamous cell carcinoma of the esophagus.
Yano M; Yasuda T; Miyata H; Fujiwara Y; Takiguchi S; Monden M
J Surg Oncol; 2005 Mar; 89(4):244-50; discussion 250. PubMed ID: 15726612
[TBL] [Abstract][Full Text] [Related]
22. Tumor budding in tumor invasive front predicts prognosis and survival of patients with esophageal squamous cell carcinomas receiving neoadjuvant chemotherapy.
Miyata H; Yoshioka A; Yamasaki M; Nushijima Y; Takiguchi S; Fujiwara Y; Nishida T; Mano M; Mori M; Doki Y
Cancer; 2009 Jul; 115(14):3324-34. PubMed ID: 19452547
[TBL] [Abstract][Full Text] [Related]
23. Influence of induction chemotherapy and class of cytotoxics on pathologic response and survival after preoperative chemoradiation in patients with carcinoma of the esophagus.
Javeri H; Arora R; Correa AM; Hofstetter WL; Lee JH; Liao Z; McAleer MF; Maru D; Bhutani MS; Swisher SG; Izzo JG; Ajani JA
Cancer; 2008 Sep; 113(6):1302-8. PubMed ID: 18623381
[TBL] [Abstract][Full Text] [Related]
24. Adjuvant chemotherapy with 5-fluorouracil and cisplatin in lymph node-positive thoracic esophageal squamous cell carcinoma.
Lee J; Lee KE; Im YH; Kang WK; Park K; Kim K; Shim YM
Ann Thorac Surg; 2005 Oct; 80(4):1170-5. PubMed ID: 16181835
[TBL] [Abstract][Full Text] [Related]
25. [Prognostically unfavorable factors in esophagus cancer. III. Operative therapy of esophagus cancer--effect of preoperative measures on prognosis in curative resection].
Weitensfelder W; Redtenbacher M; Haiderer O; Weitensfelder E
Chirurg; 1985 Mar; 56(3):161-5. PubMed ID: 3921318
[TBL] [Abstract][Full Text] [Related]
26. [Epidermoid cancer of the esophagus: role of radiotherapy and chemotherapy].
Delouche D; Haefliger JM
Rev Med Suisse Romande; 1998 Mar; 118(3):227-34. PubMed ID: 9594596
[No Abstract] [Full Text] [Related]
27. Clinical significance of the second cycle response to cisplatin-based chemotherapy as preoperative treatment for esophageal squamous cell carcinoma.
Akita H; Doki Y; Miyata H; Hirao T; Yano M; Takachi K; Miyashiro I; Sasaki Y; Ishikawa O; Ohigashi H; Imaoka S
J Surg Oncol; 2006 Apr; 93(5):401-9. PubMed ID: 16550577
[TBL] [Abstract][Full Text] [Related]
28. [A prospective study of combined chemoradiotherapy followed by surgery in the treatment of esophageal carcinoma].
An FS; Huang JQ; Xie YT; Chen SH; Rong TH
Zhonghua Zhong Liu Za Zhi; 2003 Jul; 25(4):376-9. PubMed ID: 12921571
[TBL] [Abstract][Full Text] [Related]
29. [Prospective non-randomized study of chemotherapy combined with radiotherapy versus chemotherapy alone in patients with metastatic or relapsed esophageal squamous cell carcinoma].
Zhang XD; Shen L; Li J; Li Y; Li J; Zhang XT; Jin ML
Zhonghua Zhong Liu Za Zhi; 2007 Jun; 29(6):474-7. PubMed ID: 17974288
[TBL] [Abstract][Full Text] [Related]
30. [Neoadjuvant treatment in surgery of esophageal cancer].
Launois B; Raoul JL; Leprise E; Meunier B
Bull Acad Natl Med; 2000; 184(8):1703-13; discussion 1714. PubMed ID: 11471389
[TBL] [Abstract][Full Text] [Related]
31. Neoadjuvant therapy for esophageal cancer: standard of care or elusive myth?
Boyle MJ; Franceschi D; Robinson DS; Livingstone AS
Am Surg; 2001 Oct; 67(10):956-65. PubMed ID: 11603553
[TBL] [Abstract][Full Text] [Related]
32. [Relationship between the expression of hypoxia-inducible factor-1alpha and chemotherapy response in esophageal squamous cell carcinoma].
Wu XA; Sun Y; Fan QX; Wang LX; Wang RL
Zhonghua Yi Xue Za Zhi; 2007 Jul; 87(25):1783-5. PubMed ID: 17919389
[TBL] [Abstract][Full Text] [Related]
33. [Results of stomach pull-through operations without thoracotomy in the treatment of advanced esophageal cancer].
Ulrich B; Grabitz K; Kockel N
Zentralbl Chir; 1984; 109(16):1033-43. PubMed ID: 6208708
[TBL] [Abstract][Full Text] [Related]
34. [Squamous cell cancer of the esophagus. Treatment concept at the surgical clinic of the Munich Technical University].
Siewert JR; Bartels H; Bollschweiler E; Dittler HJ; Fink U; Hölscher AH; Roder JD
Chirurg; 1992 Sep; 63(9):693-700. PubMed ID: 1382922
[No Abstract] [Full Text] [Related]
35. [A randomized clinical study of preoperative chemotherapy for esophageal carcinoma].
Wang C; Ding T; Chang L
Zhonghua Zhong Liu Za Zhi; 2001 May; 23(3):254-5. PubMed ID: 11783101
[TBL] [Abstract][Full Text] [Related]
36. Clinical markers of hypoxia and other predictive factors of survival in conservative therapy of squamous-cell carcinoma of the esophagus.
Taussky D; Rousson V; Pescia R
Int J Colorectal Dis; 2003 Mar; 18(2):167-71. PubMed ID: 12548421
[TBL] [Abstract][Full Text] [Related]
37. Hyperthermia combined with chemotherapy and irradiation for the prolongation of the postoperative prognosis in the patients with esophageal carcinoma invading neighbouring structures.
Nozoe T; Kuwano H; Sadanaga N; Watanabe M; Yasuda M; Sugimachi K
Int Surg; 1996; 81(1):21-6. PubMed ID: 8803700
[TBL] [Abstract][Full Text] [Related]
38. Concurrent preoperative chemoradiotherapy for stage III or IV esophageal squamous carcinoma.
Osaka Y; Takagi Y; Tsuchida A; Hoshino S; Tachibana S; Shinohara M; Aoki T
Oncol Rep; 2004 Nov; 12(5):1121-6. PubMed ID: 15492803
[TBL] [Abstract][Full Text] [Related]
39. The activation of Akt during preoperative chemotherapy for esophageal cancer correlates with poor prognosis.
Yoshioka A; Miyata H; Doki Y; Yasuda T; Yamasaki M; Motoori M; Okada K; Matsuyama J; Makari Y; Sohma I; Takiguchi S; Fujiwara Y; Monden M
Oncol Rep; 2008 May; 19(5):1099-107. PubMed ID: 18425364
[TBL] [Abstract][Full Text] [Related]
40. Phase II study of preoperative paclitaxel/cisplatin with radiotherapy in locally advanced esophageal cancer.
Kim DW; Blanke CD; Wu H; Shyr Y; Berlin J; Beauchamp RD; Chakravarthy B
Int J Radiat Oncol Biol Phys; 2007 Feb; 67(2):397-404. PubMed ID: 17097833
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]